BAGSVAERD, DENMARK--(Marketwire - May 2, 2012) -
Company Announcement No 31 / 2012:
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE
Further information on Novo Nordisk A/S please contact: Media: Outside North America: Anne Margrethe Hauge Tel: (+45) 4442 3450 Email Contact In North America: Ken Inchausti Tel: (+1) 609 514 8316 Email Contact Investors: Kasper Roseeuw Poulsen Tel: (+45) 4442 4303 Email Contact Frank Daniel Mersebach Tel: (+45) 4442 0604 Email Contact Lars Borup Jacobsen Tel: (+45) 3075 3479 Email Contact Jannick Lindegaard Tel: (+1) 609 786 4575 Email Contact Further information on Novo A/S please contact: Media: Henrik Gurtler CEO Tel: (+45) 3527 6575 Thorkil Kastberg Christensen CFO Tel: (+45) 3527 6592